Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 35 Breast Neoplasms 27 Prostatic Neoplasms 22 Stomach Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 12 Neoplasms 10 Lung Neoplasms 10 Urinary Bladder Neoplasms 8 Head and Neck Neoplasms 8 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Squamous Cell 6 Non-Muscle Invasive Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Transitional Cell 5 Adenocarcinoma 5 Oropharyngeal Neoplasms 4 Sarcoma 3 Prostatic Neoplasms, Castration-Resistant 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 HER2-positive Breast Cancer 3 Esophageal Squamous Cell Carcinoma 3 Endometrial Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vaccinia 2 Recurrence 2 Peritoneal Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer 2

Interventions

tislelizumab 1 pamiparib 1 Injections 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Locally Advanced Prostate Cancer × Docetaxel × Clear all

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡